FDA Slams Citizen Petition: Harsh Language, FTC Referral Suggest Tougher Stance On ANDA Delay Tactics

 
• By Brenda Sandburg
  
US FDA denies Par's citizen petition (photo illustration|Alamy image)
US FDA denies Par's citizen petition challenging vasopressin ANDA • Source: Nielsen Hobbs; the Pink Sheet|Alamy image
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Generics

More from Biosimilars & Generics